Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

Therapeutic cortical-cortical coupling in Parkinson disease.

Alhourani A, Lipski W, Richardson M.

Neurosurgery. 2015 Feb;76(2):N13-4. doi: 10.1227/01.neu.0000460592.48062.9b. No abstract available.

0

0

0

PUBMED

Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease.

Chen W, Kang WY, Chen S, Wang Y, Xiao Q, Wang G, Liu J, Chen SD.

Parkinsonism Relat Disord. 2015 Jun;21(6):610-4. doi: 10.1016/j.parkreldis.2015.03.021.

0

0

0

PUBMED

Neuroimaging in Parkinson's disease: a future perspective.

Brooks DJ.

Neurodegener Dis Manag. 2015;5(2):105-8. doi: 10.2217/nmt.14.56. No abstract available.

0

0

0

PUBMED

Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.

Schneider JS, Seyfried TN, Choi HS, Kidd SK.

PLoS One. 2015 Dec 2;10(12):e0143351. doi: 10.1371/journal.pone.0143351.

0

0

0

PUBMED

Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease.

Bastías-Candia S, Di Benedetto M, D'Addario C, Candeletti S, Romualdi P.

Environ Toxicol. 2015 May-Jun;30(6):656-63. doi: 10.1002/tox.21943.

0

0

0

PUBMED

Protective Mechanisms of Flavonoids in Parkinson's Disease.

Magalingam KB, Radhakrishnan AK, Haleagrahara N.

Oxid Med Cell Longev. 2015;2015:314560. doi: 10.1155/2015/314560. Review.

0

0

0

PUBMED

Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease.

Vadalà M, Vallelunga A, Palmieri L, Palmieri B, Morales-Medina JC, Iannitti T.

Behav Brain Funct. 2015 Sep 7;11:26. doi: 10.1186/s12993-015-0070-z. Review.

0

0

0

PUBMED

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.

Labandeira-Garcia JL, Rodríguez-Perez AI, Villar-Cheda B, Borrajo A, Dominguez-Meijide A, Guerra MJ.

Neuroscientist. 2015 Dec;21(6):616-29. doi: 10.1177/1073858414554954. Review.

0

0

0

PUBMED

Abnormal tactile pressure perception in Parkinson's disease.

Kesayan T, Lamb DG, Falchook AD, Williamson JB, Salazar L, Malaty IA, McFarland NR, Okun MS, Shukla AW, Heilman KM.

J Clin Exp Neuropsychol. 2015;37(8):808-15. doi: 10.1080/13803395.2015.1060951.

0

0

0

PUBMED

Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.

Maillet A, Thobois S, Fraix V, Redouté J, Le Bars D, Lavenne F, Derost P, Durif F, Bloem BR, Krack P, Pollak P, Debû B.

Hum Brain Mapp. 2015 Mar;36(3):959-80. doi: 10.1002/hbm.22679.

0

0

0

PUBMED

How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease?

Stegemöller EL, Schmidt P, Hass C, Malaty I, Okun MS; National Parkinson Foundation Quality Improvement Initiative Investigators..

Arch Phys Med Rehabil. 2015 Sep;96(9):1728-32. doi: 10.1016/j.apmr.2015.03.021.

0

0

0

PUBMED

Parkinson's disease: initial treatment of motor disorders.

[No authors listed]

Prescrire Int. 2015 Sep;24(163):215-7.

0

0

0

PUBMED

Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study.

Chung SJ, Kim JM, Kim JW, Jeon BS, Singh P, Thierfelder S, Ikeda J, Bauer L; Asia Pacific Rotigotine Switching Study Group..

Expert Opin Pharmacother. 2015 May;16(7):961-70. doi: 10.1517/14656566.2015.1030336.

0

0

0

PUBMED

Oscillations in pedunculopontine nucleus in Parkinson's disease and its relationship with deep brain stimulation.

Li M, Zhang W.

Front Neural Circuits. 2015 Sep 2;9:47. doi: 10.3389/fncir.2015.00047. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy